Privia Health (PRVA) Net Income towards Common Stockholders (2020 - 2026)
Privia Health (PRVA) posted Net Income towards Common Stockholders of $9.7 million for Q2 2026, up 162.37% on a QoQ basis from $3.7 million in Q1 2026, and up 200.06% year-over-year from $3.2 million in Q2 2025.
Analysis
Privia Health (PRVA) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends
Privia Health has reported Net Income towards Common Stockholders for 7 years, with the latest figure at $9.7 million in Q2 2026.
- On a quarterly basis, Net Income towards Common Stockholders rose 200.06% year-over-year to $9.7 million in Q2 2026; TTM through Jun 2026 was $33.8 million, a 81.12% increase from a year earlier, with the FY2025 full-year figure at $29.7 million, up 74.41% from the prior year.
- Net Income towards Common Stockholders was $9.7 million for Q2 2026 at Privia Health, up from $3.7 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $16.8 million in Q4 2022, with the low at -$18.1 million in Q1 2022.
- Average Net Income towards Common Stockholders over 5 years is $3.8 million, with a median of $5.0 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders slumped 422.06% in 2022, then jumped 966.55% in 2023.
- Over 5 years, Net Income towards Common Stockholders stood at $16.8 million in 2022, then slumped by 86.21% to $2.3 million in 2023, then jumped by 132.19% to $5.4 million in 2024, then soared by 96.16% to $10.6 million in 2025, then retreated by 8.04% to $9.7 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $9.7 million (Q2 2026), $3.7 million (Q1 2026), and $10.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.76 Bn | 12.64 Bn | 1.16 Bn | 343.22 Mn |
| 2 | RadNet | 5.80 Bn | 5.37 Bn | 88.08 Mn | 20.22 Mn |
| 3 | Concentra Group Holdings Parent | 4.40 Bn | 4.26 Bn | 192.10 Mn | 67.30 Mn |
| 4 | Privia Health | 2.61 Bn | 2.25 Bn | - | 9.73 Mn |
| 5 | Pediatrix Medical | 2.20 Bn | 1.79 Bn | - | 39.84 Mn |
| 6 | Fresenius Medical Care AG | 2.11 Bn | 1.41 Bn | 1.52 Bn | 253.83 Mn |
| 7 | Progyny | 2.01 Bn | 1.77 Bn | 89.30 Mn | 28.05 Mn |
| 8 | Surgery Partners | 1.87 Bn | 3.08 Bn | 622.10 Mn | 29.70 Mn |
| 9 | U S Physical Therapy | 1.18 Bn | 1.47 Bn | 41.94 Mn | 14.90 Mn |
| 10 | Starling Oncology | 595.78 Mn | 554.69 Mn | 27.17 Mn | -8.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.73 Mn |
| Mar 31, 2026 | 3.71 Mn |
| Dec 31, 2025 | 10.59 Mn |
| Sep 30, 2025 | 9.77 Mn |
| Jun 30, 2025 | 3.24 Mn |
| Mar 31, 2025 | 6.05 Mn |
| Dec 31, 2024 | 5.40 Mn |
| Sep 30, 2024 | 3.98 Mn |
| Jun 30, 2024 | 4.64 Mn |
| Mar 31, 2024 | 3.01 Mn |
| Dec 31, 2023 | 2.32 Mn |
| Sep 30, 2023 | 5.93 Mn |
| Jun 30, 2023 | 6.36 Mn |
| Mar 31, 2023 | 6.40 Mn |
| Dec 31, 2022 | 16.85 Mn |
| Sep 30, 2022 | 556,000.00 |
| Jun 30, 2022 | -11.41 Mn |
| Mar 31, 2022 | -18.09 Mn |
| Dec 31, 2021 | -11.89 Mn |
| Sep 30, 2021 | -10.89 Mn |